Kendrick Charles Morgan JR 4

4 · Elevance Health, Inc. · Filed Mar 5, 2025

Form 4

Period: 2025-03-03

EVP & President, Commercial

Transactions

Tax Payment
Common Stock
2025-03-03$395.50/sh−2,221$878,406→ 7,089 total
Award
Common Stock
2025-03-03+3,686→ 13,620 total
Award
Employee Stock Option (Right to Buy)
2025-03-03+10,828→ 10,828 total
Exercise: $395.50Exp: 2035-03-03→ Common Stock (10,828 underlying)
Award
Common Stock
2025-03-03+2,845→ 9,934 total
Sale
Common Stock
2025-03-05$396.30/sh−3,504$1,388,635→ 10,116 total

Footnotes (6)

[F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
[F2]Represents restricted share units. Restrictions lapse as follows: 948 shares each on 3/3/2026 and 3/3/2027, and 949 shares on 3/3/2028.
[F3]Represents performance based restricted share units. Restrictions lapse on 3/3/2025.
[F4]This transaction was executed in multiple trades, each at the same price of $396.30.
[F5]Balance includes 22.89 shares acquired on December 20, 2024 through a dividend reinvestment plan.
[F6]The option represents a right to purchase a total of 10,828 shares, and is exercisable in three annual installments, with two installments of 3,609 shares each and one installment of 3,610 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.

Documents

1 file